Roche Holding AG 2015 AR2
The report highlights Roche's strong performance in 2015, with Group sales increasing by 5% to CHF 48.1 billion, driven by demand in oncology, immunology, and professional diagnostics. The company made significant pipeline progress, receiving five major drug approvals and four FDA breakthrough therapy designations, including positive phase III results for ocrelizumab in multiple sclerosis. Roche was recognized as the healthcare sector leader in the Dow Jones Sustainability Indices for the seventh consecutive year and achieved a top score from the CDP for climate change mitigation. Additionally, the company advanced its global access planning strategy, launching the HIV Global Access Programme to expand diagnostic testing in low- and middle-income countries.
Company: Roche Holding AG
Sector: Manufacturing
Country: Switzerland
Year: 2015
Type: AR2
Pages: 103
Back to company
Roche Holding AG
Annual Report
The report highlights Roche's strong performance in 2015, with Group sales increasing by 5% to CHF 48.1 billion, driven by demand in oncology, immunology, and professional diagnostics. The company made significant pipeline progress, receiving five major drug approvals and four FDA breakthrough therapy designations, including positive phase III results for ocrelizumab in multiple sclerosis. Roche was recognized as the healthcare sector leader in the Dow Jones Sustainability Indices for the seventh consecutive year and achieved a top score from the CDP for climate change mitigation. Additionally, the company advanced its global access planning strategy, launching the HIV Global Access Programme to expand diagnostic testing in low- and middle-income countries.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Jan 1, 2015 - Dec 31, 2015
Fiscal Year
2015
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Women in Management
Employees